In July 2022, researchers from Columbia University Medical Center (Department of Pediatrics), Children’s Hospital of Michigan (Division of Hematology), and Erasmus Medical Center University Medical Center Sophia Children’s Hospital (Department of Pediatric Hematology and Oncology) reviewed the use of unfractionated heparin (UFH) and direct thrombin inhibitors (DTIs) in pediatric patients with extracorporeal membrane oxygenation (ECMO)…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest